{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T10:50:18Z","timestamp":1782816618304,"version":"3.54.5"},"reference-count":39,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009,12]]},"DOI":"10.1097\/mbc.0b013e32832f6c5b","type":"journal-article","created":{"date-parts":[[2009,10,29]],"date-time":"2009-10-29T07:17:35Z","timestamp":1256800655000},"page":"646-651","source":"Crossref","is-referenced-by-count":11,"title":["The influence of low-dose aspirin and hydroxyurea on platelet\u2013leukocyte interactions in patients with essential thrombocythemia"],"prefix":"10.1097","volume":"20","author":[{"given":"Jacek","family":"Treli\u0144ski","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marzena","family":"Tybura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piotr","family":"Smolewski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tadeusz","family":"Robak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krzysztof","family":"Chojnowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-6-20210203","doi-asserted-by":"crossref","first-page":"2658","DOI":"10.1002\/1097-0142(19910515)67:10<2658::AID-CNCR2820671042>3.0.CO;2-C","article-title":"Life expectancy of patients with chronic nonleukemic myeloproliferative disorders","volume":"67","author":"Rozman","year":"1991","journal-title":"Cancer"},{"key":"R2-6-20210203","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1007\/s002779900136","article-title":"Myeloproliferative disorders: complications, survival and causes of death","volume":"79","author":"Brodmann","year":"2000","journal-title":"Ann Hematol"},{"key":"R3-6-20210203","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1111\/j.1365-2141.2004.05277.x","article-title":"Thrombosis and haemorrhage in polycythaemia vera and essential thrombocythaemia","volume":"128","author":"Elliott","year":"2005","journal-title":"Br J Haematol"},{"key":"R4-6-20210203","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1016\/0277-5379(83)90091-3","article-title":"Thrombohaemorrhagic complications in 101 cases of myeloproliferative disorders: relationship to platelet number and function","volume":"19","author":"Barbui","year":"1983","journal-title":"Eur J Cancer Clin Oncol"},{"key":"R5-6-20210203","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1093\/ajcp\/95.1.82","article-title":"Platelet aggregation in platelet-rich plasma and whole blood in 120 patients with myeloproliferative disorders","volume":"95","author":"Balduini","year":"1991","journal-title":"Am J Clinical Pathol"},{"key":"R6-6-20210203","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1046\/j.1365-2141.1999.01399.x","article-title":"Thrombosis and bleeding in myeloproliferative disorders: identification of at-risk patients with whole blood platelet aggregation studies","volume":"105","author":"Manoharan","year":"1999","journal-title":"Br J Haematol"},{"key":"R7-6-20210203","doi-asserted-by":"crossref","first-page":"2310","DOI":"10.1182\/blood-2006-09-046342","article-title":"Leukocytosis is a risk factor for thrombosis in essential thrombocythemia:interaction with treatment, standard risk factors, and Jak2 mutation status","volume":"109","author":"Carobbio","year":"2007","journal-title":"Blood"},{"key":"R8-6-20210203","doi-asserted-by":"crossref","first-page":"4261","DOI":"10.1182\/blood.V96.13.4261","article-title":"Polymorphonuclear leukocyte activation and hemostasis in patients with essential thrombocythemia and polycythemia vera","volume":"96","author":"Falanga","year":"2000","journal-title":"Blood"},{"key":"R9-6-20210203","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1053\/j.seminhematol.2005.05.023","article-title":"Pathogenesis of thrombosis in essential thrombocythemia and polycythemia vera: the role of neutrophils","volume":"42","author":"Falanga","year":"2005","journal-title":"Semin Hematol"},{"key":"R10-6-20210203","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1034\/j.1600-0609.2001.00359.x","article-title":"Increased circulating platelet-leukocyte aggregates in myeloproliferative disorders is correlated to previous thrombosis, platelet activation and platelet count","volume":"66","author":"Jensen","year":"2001","journal-title":"Eur J Haematol"},{"key":"R11-6-20210203","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.exphem.2005.01.015","article-title":"Leukocyte-platelet interaction in patients with essential thrombocythemia and polycythemia vera","volume":"33","author":"Falanga","year":"2005","journal-title":"Exp Hematol"},{"key":"R12-6-20210203","first-page":"169","article-title":"Increased platelet and leukocyte activation as contributing mechanisms for thrombosis in essential thrombocythemia and correlation with the JAK2 mutational status","volume":"91","author":"Arellano-Rodrigo","year":"2006","journal-title":"Haematologica"},{"key":"R13-6-20210203","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0049-3848(02)00354-7","article-title":"Markers of platelet activation and platelet-leukocyte interaction in patients with myeloproliferative syndromes","volume":"108","author":"Villmow","year":"2002","journal-title":"Thromb Res"},{"key":"R14-6-20210203","doi-asserted-by":"crossref","first-page":"331","DOI":"10.3324\/haematol.12604","article-title":"Prevention of thrombosis in polycythemia vera and essential thrombocythemia","volume":"93","author":"Landolfi","year":"2008","journal-title":"Haematologica"},{"key":"R15-6-20210203","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1038\/leu.2008.177","article-title":"Evidence and expertise in the management of polycythemia vera and essential thrombocythemia","volume":"22","author":"Finazzi","year":"2008","journal-title":"Leukemia"},{"key":"R16-6-20210203","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1056\/NEJM199504273321704","article-title":"Hydroxyurea for patients with essential thrombocythemia and a high risk of thrombosis","volume":"332","author":"Cortelazzo","year":"1995","journal-title":"N Engl J Med"},{"key":"R17-6-20210203","first-page":"29","article-title":"Experience of the Polycythemia Vera Study Group with essential thrombocythemia: a final report on diagnostic criteria, survival, and leukemic transition by treatment","volume":"34","author":"Murphy","year":"1997","journal-title":"Semin Hematol"},{"key":"R18-6-20210203","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1055\/s-0038-1657599","article-title":"Mechanisms of bleeding and thrombosis in myeloproliferative disorders","volume":"78","author":"Landolfi","year":"1997","journal-title":"Thromb Haemost"},{"key":"R19-6-20210203","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1200\/JCO.1990.8.3.556","article-title":"Incidence and risk factors for thrombotic complications in a historical cohort of 100 patients with essential thrombocythemia","volume":"8","author":"Cortelazzo","year":"1990","journal-title":"J Clin Oncol"},{"key":"R20-6-20210203","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1182\/asheducation-2007.1.363","article-title":"Thrombocytosis and thrombosis","volume":"2007","author":"Vannucchi","year":"2007","journal-title":"Hematol Am Soc Hematol Educ Program"},{"key":"R21-6-20210203","doi-asserted-by":"crossref","first-page":"159","DOI":"10.4065\/81.2.159","article-title":"Essential thrombocythemia beyond the first decade: life expectancy, long-term complication rates, and prognostic factors","volume":"81","author":"Wolanskyj","year":"2006","journal-title":"Mayo Clin Proc"},{"key":"R22-6-20210203","first-page":"41","article-title":"Recent advances in plateletpolymorphonuclear leukocyte interaction","volume":"29","author":"de Gaetano","year":"1999","journal-title":"Haemostasis"},{"key":"R23-6-20210203","doi-asserted-by":"crossref","first-page":"7462","DOI":"10.1073\/pnas.85.20.7462","article-title":"Adhesive receptor MAC-1 coordinates the action of factor X on stimulated cells of monocyte and myeloid differentiation: an alternative initiation of the coagulation protease cascades","volume":"85","author":"Altieri","year":"1988","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R24-6-20210203","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1046\/j.1365-2141.2000.02030.x","article-title":"Increased platelet activation and abnormal membrane glycoprotein content and redistribution in myeloproliferative disorders","volume":"110","author":"Jensen","year":"2000","journal-title":"Br J Haematol"},{"key":"R25-6-20210203","doi-asserted-by":"crossref","first-page":"2214","DOI":"10.1161\/01.STR.28.11.2214","article-title":"Soluble adhesion molecules reflect endothelial cell activation in ischemic stroke and in carotid atherosclerosis","volume":"28","author":"Frijns","year":"1997","journal-title":"Stroke"},{"key":"R26-6-20210203","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1055\/s-0037-1616132","article-title":"Flow cytometry detection of platelet procoagulation activity and microparticles in patients with unstable angina treated by percutaneous coronary angioplasty and stent implantation","volume":"86","author":"Vidal","year":"2001","journal-title":"Thromb Haemost"},{"key":"R27-6-20210203","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S0049-3848(99)00095-X","article-title":"Increased platelet surface expression of P-selectin and thrombospondin as markers of platelet activation in essential thrombocythaemia","volume":"96","author":"Griesshammer","year":"1999","journal-title":"Thromb Res"},{"key":"R28-6-20210203","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1056\/NEJMoa043800","article-title":"United Kingdom Medical Research Council Primary Thrombocythemia 1 study. Hydroxyurea compared with anagrelide in high-risk essential thrombocythemia","volume":"353","author":"Harrison","year":"2005","journal-title":"N Engl J Med"},{"key":"R29-6-20210203","doi-asserted-by":"crossref","first-page":"4183","DOI":"10.1182\/blood.V88.11.4183.4183","article-title":"Platelet\/polymorphonuclear leukocyte interaction in dynamic conditions: evidence of adhesion cascade and cross talk between P-selectin and beta 2 integrin CD11b\/CD18","volume":"88","author":"Evangelista","year":"1996","journal-title":"Blood"},{"key":"R30-6-20210203","first-page":"1","article-title":"Mechanism of action of hydroxyurea","volume":"19","author":"Yarbro","year":"1992","journal-title":"Semin Oncol"},{"key":"R31-6-20210203","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1182\/blood.V98.1.108","article-title":"Platelet\/polymorphonuclear leukocyte adhesion: a new role for SRC kinases in MAC-1 adhesive function triggered by P-selectin","volume":"98","author":"Piccardoni","year":"2001","journal-title":"Blood"},{"key":"R32-6-20210203","doi-asserted-by":"crossref","first-page":"2593","DOI":"10.1111\/j.1538-7836.2006.02194.x","article-title":"Inhibition of tissue factor expression by hydroxyurea in polymorphonuclear leukocytes from patients with myeloproliferative disorders: a new effect for an old drug?","volume":"4","author":"Maugeri","year":"2006","journal-title":"J Thromb Haemost"},{"key":"R33-6-20210203","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1046\/j.1365-2141.1997.d01-2127.x","article-title":"Prevention and treatment of thrombotic complications in essential thrombocythemia: efficacy and safety of low-dose aspirin","volume":"97","author":"Van Genderen","year":"1997","journal-title":"Br J Haematol"},{"key":"R34-6-20210203","doi-asserted-by":"crossref","first-page":"2224","DOI":"10.1200\/JCO.2005.07.062","article-title":"Vascular and neoplastic risk in a large cohort of patients with polycythemia vera","volume":"23","author":"Marchioli","year":"2005","journal-title":"J Clin Oncol"},{"key":"R35-6-20210203","doi-asserted-by":"crossref","first-page":"372","DOI":"10.3324\/haematol.12053","article-title":"Recurrent thrombosis in patients with polycythemia vera and essential thrombocythemia: incidence, risk factors, and effect of treatments","volume":"93","author":"De Stefano","year":"2008","journal-title":"Haematologica"},{"key":"R36-6-20210203","doi-asserted-by":"crossref","first-page":"2373","DOI":"10.1056\/NEJMra052717","article-title":"Low-dose aspirin for the prevention of atherothrombosis","volume":"353","author":"Patrono","year":"2005","journal-title":"N Engl J Med"},{"key":"R37-6-20210203","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.thromres.2003.08.026","article-title":"Aspirin treatment does not attenuate platelet or leukocyte activation as monitored by whole blood flow cytometry","volume":"111","author":"Li","year":"2003","journal-title":"Thromb Res"},{"key":"R38-6-20210203","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1067\/mcp.2003.13","article-title":"Clopidogrel but not aspirin reduces P-selectin expression and formation of platelet-leukocyte aggregates in patients with atherosclerotic vascular disease","volume":"73","author":"Klinkhardt","year":"2003","journal-title":"Clin Pharmacol Ther"},{"key":"R39-6-20210203","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1007\/s11239-007-0190-x","article-title":"The effects of antiplatelet agents on platelet-leukocyte aggregations in patients with acute cerebral infarction","volume":"27","author":"Cao","year":"2009","journal-title":"J Thromb Thrombolysis"}],"container-title":["Blood Coagulation &amp; Fibrinolysis"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/journals.lww.com\/00001721-200912000-00006","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,10]],"date-time":"2021-04-10T06:10:44Z","timestamp":1618035044000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00001721-200912000-00006"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,12]]},"references-count":39,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2009]]}},"URL":"https:\/\/doi.org\/10.1097\/mbc.0b013e32832f6c5b","relation":{},"ISSN":["0957-5235"],"issn-type":[{"value":"0957-5235","type":"print"}],"subject":[],"published":{"date-parts":[[2009,12]]}}}